Clinical Trials Logo

Shock clinical trials

View clinical trials related to Shock.

Filter by:

NCT ID: NCT01722422 Terminated - Septic Shock Clinical Trials

Hyperoxia and Hypertonic Saline in Septic Shock

Hyper2S
Start date: October 2012
Phase: N/A
Study type: Interventional

Assessment of the effect of hyperoxia and hypertonic saline on survival in patients with septic shock Hyperoxia and hypertonic saline may have beneficial effects on organ perfusion and oxygenation and may reduce the organ failure occurences. To date, only scarce data are available. Side effects are not well described. Therefore we designed a randomized clinical trial in order to assess the early administration of hypertonic saline and oxygen in the very early beginning of septic shock.

NCT ID: NCT01696175 Terminated - Shock Clinical Trials

PICU Admission Lactate and Central Venous Oxymetry Study

PALVOS
Start date: September 2012
Phase: N/A
Study type: Observational

Observational multicentre cohort study. Children admitted to a Dutch PICU are studied for lactate levels and ScvO2. Children instrumented with arterial and central venous catheters are included within the first 12 hours after admittance.

NCT ID: NCT01683747 Terminated - Sepsis Clinical Trials

Single Dose Enteral Tranexamic Acid in Critically Ill Patients

Start date: June 2012
Phase: Phase 2
Study type: Interventional

The premise of this study is that enteral tranexamic acid will help to maintain small bowel integrity, which is often compromised by critical illness due to inadequate cardiovascular perfusion (i.e., shock), and that maintenance of small bowel integrity will decrease morbidity in critically ill patients.

NCT ID: NCT01682590 Terminated - Septic Shock Clinical Trials

I.D.E.A.L.-I.C.U. (Initiation of Dialysis EArly Versus deLayed in Intensive Care Unit)

IDEAL-ICU
Start date: July 2012
Phase: Phase 3
Study type: Interventional

The purpose of this multicentric, randomized controlled trial is to assess whether the timing of renal replacement therapy initiation (early vs delayed) has an impact on mortality at 90 days in patients with severe acute kidney injury at the failure stage (according to RIFLE criteria) during the initial phase of septic shock.

NCT ID: NCT01653977 Terminated - Surgery Clinical Trials

Impact of Early Goal-directed Fluid Therapy in Hypovolemic Patients Undergoing Emergency Surgery

Start date: February 2010
Phase: N/A
Study type: Interventional

This study compares the safety and efficacy of GDTs using standard pressure-related parameters vs. dynamic hemodynamic indices associated with fluid compartment monitoring, in trauma patients requiring emergency surgery.

NCT ID: NCT01639664 Terminated - Shock, Septic Clinical Trials

COMPACT 2 - COMbining Plasma-filtration and Adsorption Clinical Trial 2

COMPACT-2
Start date: September 2013
Phase: N/A
Study type: Interventional

The study objective is to clarify whether the application of high doses CPFA (coupled plasma-filtration adsorption) in addition to the current clinical practice is able to reduce hospital mortality in septic shock patients in intensive care unit (ICU).

NCT ID: NCT01587963 Terminated - Shock Clinical Trials

High Dose Vitamin C in the Critically Ill Patient

VitC
Start date: February 2013
Phase: Phase 2
Study type: Interventional

It has been shown that the stress that occurs during trauma, infection and/or shock depletes many of the body's resources such as Vitamin C (ascorbic acid) which may contribute to further complications. The purpose of this study is to determine the effectiveness of high doses of Vitamin C in critically ill patients.

NCT ID: NCT01550198 Terminated - Clinical trials for Impact of Advanced Hemodynamic Monitoring

Early Detection of Neonatal Shock

Edscini
Start date: May 2013
Phase:
Study type: Observational

The purpose of this study is to evaluate the hypothesis that advanced hemodynamic monitoring results in an earlier detection of circulatory failure in newborn infants

NCT ID: NCT01493102 Terminated - Septic Shock Clinical Trials

Discontinuation Order of Vasopressors in Septic Shock

DOVSS
Start date: December 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the incidence of hypotension based on the discontinuation order of norepinephrine and vasopressin in patients receiving concomitant norepinephrine and vasopressin infusions for the treatment of septic shock.

NCT ID: NCT01455116 Terminated - Septic Shock Clinical Trials

The Cooling And Surviving Septic Shock Study (CASS)

CASS
Start date: November 2011
Phase: Phase 2/Phase 3
Study type: Interventional

Septic shock is in critically ill patients is a condition associated with a high rate of organ failure and hereto attributable mortality ~45-55% Hypothesis: Mild Induced Hypothermia reduces the mortality of critically ill patients with septic shock by reducing organ metabolism, counteracting on microcirculatory thrombosis, genetically downregulating tissue apoptosis and by reducing bacterial growth rate and toxin production.